C4 Therapeutics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CCCC and other ETFs, options, and stocks.About CCCC
C4 Therapeutics, Inc. engages in the development of targeted protein degradation science to develop a new generation of small molecule medicines used for treating diseases. It develops the Degronimid platform that incorporates small molecule binders to target disease-causing proteins and facilitate their destruction and clearance from the cell through the natural ubiquitin and proteasome system.
CCCC Key Statistics
Stock Snapshot
As of today, C4 Therapeutics(CCCC) shares are valued at $3.61. The company's market cap stands at 394.72M, with a P/E ratio of -3.02.
As of 2026-06-09, C4 Therapeutics(CCCC) stock has fluctuated between $3.44 and $3.87. The current price stands at $3.61, placing the stock +4.9% above today's low and -6.7% off the high.
The C4 Therapeutics(CCCC)'s current trading volume is 1.65M, compared to an average daily volume of 2.67M.
In the last year, C4 Therapeutics(CCCC) shares hit a 52-week high of $4.60 and a 52-week low of $1.36.
In the last year, C4 Therapeutics(CCCC) shares hit a 52-week high of $4.60 and a 52-week low of $1.36.
Analyst ratings
100%
of 8 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.